Skip to content

MiniMizer for Sleeve Optimization

MiniMizer for Sleeve Optimization - MISO

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00007729
Enrollment
94
Registered
2015-01-30
Start date
2015-01-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66

Interventions

Group 1: laparoscopic sleeve gastrectomy without MiniMizer Ring Group 2: laparoscopic sleeve gastrectomy with MiniMizer Ring

Sponsors

Universitätsklinikum Freiburg Abt. Allgemein- und Viszeralchirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 64 Years

Inclusion criteria

Inclusion criteria: ->18 and = 35kg/m2 and existence of obesety-related comorbiditys as there are: type 2 diabetes mellitus, arterial hypertension, sleep apnea, degenerative diseases of the spine or knees, or BMI >=40kg/m2, signed informed consent

Exclusion criteria

Exclusion criteria: -history of obesity surgery -history of major abdominal surgery with resection of the stomach, small and large bowel (exception: appendectomym cholecystectomy, umbilical hernia repair, incisional hernia repair, ingual hernia repair), Patients not eligible to implement silastic ring, history of drug or alcohol abuse, history of major psychiatric illness conflicting with patient´s compliance, lack of compliance, autoimmune disease, inflammatory bowel disease or malabsorptive disease, liver cirrhosis (CHILD A, B, C), active viral or bacterial disease, pregnant women or women with childbearing potential without efficient contraception, history of cancer in the last five years, severe gastroesophageal reflux disease with Barrett´s dysplasia or hiatal hernia >5cm

Design outcomes

Primary

MeasureTime frame
Weight loss after 36 months

Secondary

MeasureTime frame
HbA1c, number of antidiabetic drugs, blood pressure, number of antihypertension drugs, triglycerides, LDL, HDL, total cholersterol, occurence of reflux, dysphagia, occurence of adverse events, operation time, hosptal stay, Occurence of postsurgical regurgitation after 1, 3, 6, 12 and 36 months, volume of gastric sleeve after 1 and 3 years (MRI)

Countries

Germany

Contacts

Public ContactJodok Fink

Universitätsklinikum Freiburg Abt. Allgemein- und Viszeralchirurgie

jodok.fink@uniklinik-freiburg.de0761/270-24010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 18, 2026